<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345715</id>
  <title nil="true"/>
  <common-name>3-[2-(1,3-benzothiazol-2-yl)phenyl]-6,8-dibromo-2-phenylquinazolin-4-one</common-name>
  <description>3-[2-(1,3-benzothiazol-2-yl)phenyl]-6,8-dibromo-2-phenylquinazolin-4-one is a chemical compound with the formula C27H15Br2N3OS. With an average molecular weight of 589.30 g/mol, 3-[2-(1,3-benzothiazol-2-yl)phenyl]-6,8-dibromo-2-phenylquinazolin-4-one is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>63830</pubchem-id>
  <chemical-formula>C27H15Br2N3OS</chemical-formula>
  <weight>589.3</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:40:55Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:40:55Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C=C1)C2=NC3=C(C=C(C=C3Br)Br)C(=O)N2C4=CC=CC=C4C5=NC6=CC=CC=C6S5</moldb-smiles>
  <moldb-formula>C27H15Br2N3OS</moldb-formula>
  <moldb-inchi>InChI=1S/C27H15Br2N3OS/c28-17-14-19-24(20(29)15-17)31-25(16-8-2-1-3-9-16)32(27(19)33)22-12-6-4-10-18(22)26-30-21-11-5-7-13-23(21)34-26/h1-15H</moldb-inchi>
  <moldb-inchikey>NMCPXNSSBDZQRO-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">586.93026</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>7.6</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341608</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[2-(1,3-benzothiazol-2-yl)phenyl]-6,8-dibromo-2-phenylquinazolin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazanaphthalenes</klass>
  <subklass>Benzodiazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296071</sync-id>
  <structure-inchikey>NMCPXNSSBDZQRO-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>20000000000000000000000200000000500000200000000080000020040000000000000000044000002000800000000000040000000000000000000000200000100000000000008080000000000000000000800040000000001004000004000001020000000008800000000000000000000000008040000000002000008000000001000000000000000000000001000000000000000400000800000000000008000000000000000000000000000400000000000020000001000100008000000000020028200002000400000000000000000000010000401000000000000a0000000000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJwAAAIABBkBoAAAAAwMBBkBoAAAA
AwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAAD
BAdAKAAAAAMDBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAKAAAAAMEBkBo
AAAAAwMBBkAoAAAAAwQjACAAAAABIwAgAAAAAQZAKAAAAAMECAAoAAAAAwIH
QCgAAAADAwZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBo
AAAAAwMBBkAoAAAAAwQGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQGgAAAAD
AwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBBBAKAAAAAMC
CwABaAwBAmgMAgNoDAMEaAwEBWgMAwYgBgdoDAcIaAwICWgMCQpoDAoLaAwL
DGgMDA1oDA0OAAsPAAkQaAwQESgCEBJoDBITIBMUaAwUFWgMFRZoDBYXaAwX
GGgMGBkgGRpoDBobaAwbHGgMHB1oDB0eaAweH2gMHyBoDCAhaAwFAGgMEgZo
DA0IaAwYE2gMIRloDCAbaAxCBgAAAAYABQQDAgEGBwgJEBIGBgoLDA0ICQYU
FRYXGBMFGhkhIBsGHB0eHyAbFwQAAAAAAAAAFg==
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:40Z</structure-indexed-at>
</compound>
